To enhance obesity therapy in the pediatric population, more research is required to examine the dynamics of GIP and GLP-1 production relative to Tanner stages and the long-term impacts on muscle development, bone density, and sexual maturation. This evidence concerns the gene GLP1R and obesity disorder.